Literature DB >> 11277269

Collagen metabolism is markedly altered in the hypertrophic cartilage of growth plates from rats with growth impairment secondary to chronic renal failure.

J Alvarez1, M Balbín, M Fernández, J M López.   

Abstract

Skeletal growth depends on growth plate cartilage activity, in which matrix synthesis by chondrocytes is one of the major processes contributing to the final length of a bone. On this basis, the present work was undertaken to ascertain if growth impairment secondary to chronic renal insufficiency is associated with disturbances of the extracellular matrix (ECM) of the growth plate. By combining stereological and in situ hybridization techniques, we examined the expression patterns of types II and X collagens and collagenase-3 in tibial growth plates of rats made uremic by subtotal nephrectomy (NX) in comparison with those of sham-operated rats fed ad libitum (SAL) and sham-operated rats pair-fed with NX (SPF). NX rats were severely uremic, as shown by markedly elevated serum concentrations of urea nitrogen, and growth retarded, as shown by significantly decreased longitudinal bone growth rates. NX rats showed disturbances in the normal pattern of chondrocyte differentiation and in the rates and degree of substitution of hypertrophic cartilage with bone, which resulted in accumulation of cartilage at the hypertrophic zone. These changes were associated with an overall decrease in the expression of types II and X collagens, which was especially marked in the abnormally extended zone of the hypertrophic cartilage. Unlike collagen, the expression of collagenase-3 was not disturbed severely. Electron microscopic analysis proved that changes in gene expression were coupled to alterations in the mineralization as well as in the collagen fibril architecture at the hypertrophic cartilage. Because the composition and structure of the ECM have a critical role in regulating the behavior of the growth plate chondrocytes, results obtained are consistent with the hypothesis that alteration of collagen metabolism in these cells could be a key process underlying growth retardation in uremia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277269     DOI: 10.1359/jbmr.2001.16.3.511

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  Growth plate alterations in chronic kidney disease.

Authors:  Ángela Fernández-Iglesias; José Manuel López; Fernando Santos
Journal:  Pediatr Nephrol       Date:  2018-12-14       Impact factor: 3.714

2.  Growth plate height of uremic rats is influenced by severity and duration of renal failure.

Authors:  Marta Fernández-Fuente; Fernando Santos; Eduardo Carbajo-Pérez; Julián Rodríguez; Ana Weruaga; Benito Amil; Inés Molinos; Enrique García
Journal:  Pediatr Nephrol       Date:  2003-12-16       Impact factor: 3.714

Review 3.  Growth-plate cartilage in chronic renal failure.

Authors:  Cheryl P Sanchez
Journal:  Pediatr Nephrol       Date:  2009-10-09       Impact factor: 3.714

Review 4.  Alterations of the growth plate in chronic renal failure.

Authors:  Fernando Santos; Eduardo Carbajo-Pérez; Julián Rodríguez; Marta Fernández-Fuente; Inés Molinos; Benito Amil; Enrique García
Journal:  Pediatr Nephrol       Date:  2004-11-10       Impact factor: 3.714

Review 5.  Hedgehog signaling underlying tendon and enthesis development and pathology.

Authors:  Fei Fang; McKenzie Sup; Andrew Luzzi; Xavier Ferrer; Stavros Thomopoulos
Journal:  Matrix Biol       Date:  2021-12-24       Impact factor: 11.583

Review 6.  Acquiring chondrocyte phenotype from human mesenchymal stem cells under inflammatory conditions.

Authors:  Masahiro Kondo; Kunihiro Yamaoka; Yoshiya Tanaka
Journal:  Int J Mol Sci       Date:  2014-11-17       Impact factor: 5.923

7.  Innovative Three-Dimensional Microscopic Analysis of Uremic Growth Plate Discloses Alterations in the Process of Chondrocyte Hypertrophy: Effects of Growth Hormone Treatment.

Authors:  Ángela Fernández-Iglesias; Rocío Fuente; Helena Gil-Peña; Laura Alonso-Durán; María García-Bengoa; Fernando Santos; José Manuel López
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.